Flecainide acetate 50 MG Oral Tablet — RxCUI 886662
RxNorm drug concept · Semantic clinical drug
RxCUI 886662
Semantic clinical drug · SCD
● Current RxNorm concept 43 FDA products
79 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI886662
Official nameFlecainide acetate 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped43
Package NDCs mapped79
Reported Medicaid activity (SDUD)82,857 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Flecainide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Flecainide slows down the electrical signals in your heart — think of it as turning down the speed on chaotic or too-fast electrical firing. This helps your heart stay in a normal,...
- What is flecainide actually doing for my heart?
- Yes, and this is the most important thing to know about this medication. Like other antiarrhythmics, flecainide can sometimes trigger new or more dangerous heart rhythms — this is...
- Can flecainide actually make my heart rhythm worse?
🕸️ Concept Web — How Flecainide acetate 50 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Flecainide acetate 50 MG Oral Tablet
RxCUI 886662 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Flecainide
4441IN -
Flecainide acetate
42686PIN
-
Flecainide
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Flecainide Oral Tablet
498897SCDF -
Flecainide acetate Oral Tablet
2647064SCDFP -
Flecainide Oral Product
1160223SCDG -
Flecainide Pill
1160224SCDG -
Flecainide acetate Oral Product
2662984SCDGP -
Flecainide acetate Pill
2663094SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Flecainide Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Flecainide acetate 50 MG
886661SCDC
-
Flecainide acetate 50 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Flecainide acetate 50 MG
SCDC · 886661 -
Flecainide Oral Tablet
SCDF · 498897 -
Flecainide acetate Oral Tablet
SCDFP · 2647064 -
Flecainide Oral Product
SCDG · 1160223 -
Flecainide Pill
SCDG · 1160224 -
Flecainide acetate Oral Product
SCDGP · 2662984 -
Flecainide acetate Pill
SCDGP · 2663094
📦 FDA Products & Package NDCs
43 products · 79 package NDCs
79 package NDCs map to RxCUI 886662 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65862-0621-30 | 30 TABLET in 1 BOTTLE (65862-621-30) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0621-99 | 1000 TABLET in 1 BOTTLE (65862-621-99) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0622-01 | 100 TABLET in 1 BOTTLE (65862-622-01) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0622-30 | 30 TABLET in 1 BOTTLE (65862-622-30) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0622-99 | 1000 TABLET in 1 BOTTLE (65862-622-99) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0623-01 | 100 TABLET in 1 BOTTLE (65862-623-01) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0623-30 | 30 TABLET in 1 BOTTLE (65862-623-30) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 65862-0623-99 | 1000 TABLET in 1 BOTTLE (65862-623-99) | Flecainide Acetate | Aurobindo Pharma Limited | 2017-11-03 |
| 71335-1487-01 | 30 TABLET in 1 BOTTLE (71335-1487-1) | Flecainide Acetate | Bryant Ranch Prepack | 2020-01-17 |
| 71335-1487-02 | 60 TABLET in 1 BOTTLE (71335-1487-2) | Flecainide Acetate | Bryant Ranch Prepack | 2020-03-19 |
| 71335-1487-03 | 90 TABLET in 1 BOTTLE (71335-1487-3) | Flecainide Acetate | Bryant Ranch Prepack | 2021-12-28 |
| 71335-1487-04 | 10 TABLET in 1 BOTTLE (71335-1487-4) | Flecainide Acetate | Bryant Ranch Prepack | 2021-12-28 |
| 71335-1487-05 | 180 TABLET in 1 BOTTLE (71335-1487-5) | Flecainide Acetate | Bryant Ranch Prepack | 2025-09-23 |
| 71335-2995-01 | 30 TABLET in 1 BOTTLE (71335-2995-1) | Flecainide Acetate | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2995-02 | 60 TABLET in 1 BOTTLE (71335-2995-2) | Flecainide Acetate | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2995-03 | 90 TABLET in 1 BOTTLE (71335-2995-3) | Flecainide Acetate | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2995-04 | 10 TABLET in 1 BOTTLE (71335-2995-4) | Flecainide Acetate | Bryant Ranch Prepack | 2026-02-04 |
| 71335-2995-05 | 180 TABLET in 1 BOTTLE (71335-2995-5) | Flecainide Acetate | Bryant Ranch Prepack | 2026-02-04 |
| 72162-1760-01 | 100 TABLET in 1 BOTTLE (72162-1760-1) | Flecainide Acetate | Bryant Ranch Prepack | 2023-08-30 |
| 72789-0385-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-385-01) | Flecainide Acetate | PD-Rx Pharmaceuticals, Inc. | 2024-02-27 |
| 72789-0385-60 | 60 TABLET in 1 BOTTLE, PLASTIC (72789-385-60) | Flecainide Acetate | PD-Rx Pharmaceuticals, Inc. | 2024-02-27 |
| 72789-0385-93 | 180 TABLET in 1 BOTTLE, PLASTIC (72789-385-93) | Flecainide Acetate | PD-Rx Pharmaceuticals, Inc. | 2024-02-27 |
| 76385-0145-01 | 100 TABLET in 1 BOTTLE (76385-145-01) | Flecainide Acetate | UNICHEM PHARMACEUTICALS (USA), INC. | 2024-01-11 |
| 76385-0145-60 | 60 TABLET in 1 BOTTLE (76385-145-60) | Flecainide Acetate | UNICHEM PHARMACEUTICALS (USA), INC. | 2024-01-11 |
| 76385-0146-01 | 100 TABLET in 1 BOTTLE (76385-146-01) | Flecainide Acetate | UNICHEM PHARMACEUTICALS (USA), INC. | 2024-01-11 |
| 76385-0146-60 | 60 TABLET in 1 BOTTLE (76385-146-60) | Flecainide Acetate | UNICHEM PHARMACEUTICALS (USA), INC. | 2024-01-11 |
| 76385-0147-01 | 100 TABLET in 1 BOTTLE (76385-147-01) | Flecainide Acetate | UNICHEM PHARMACEUTICALS (USA), INC. | 2024-01-15 |
| 76385-0147-60 | 60 TABLET in 1 BOTTLE (76385-147-60) | Flecainide Acetate | UNICHEM PHARMACEUTICALS (USA), INC. | 2024-01-15 |
| 82804-0155-30 | 30 TABLET in 1 BOTTLE (82804-155-30) | Flecainide Acetate | Proficient Rx LP | 2024-10-03 |
Observed labelers:
Bryant Ranch Prepack (18) ·
Aurobindo Pharma Limited (9) ·
Hikma Pharmaceuticals USA Inc. (9) ·
Amneal Pharmaceuticals LLC (6) ·
Amneal Pharmaceuticals of New York LLC (6) ·
UNICHEM PHARMACEUTICALS (USA), INC. (6)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.